OAS3 and COVID-19: Banday et al. (2022) investigated the influence of OAS1 rs10774671 on COVID-19 hospitalization outcomes and suggested that it has a functional impact on disease severity (Banday et al., 2022). Similarly, the GenOMICC study by Pairo-Castineira et al. identified a potential role for OAS3 rs10735079 in the progression to critical illness in COVID-19 patients (Pairo-Castineira et al., 2020).